Post-traumatic stress disorder (PTSD) is a mental disorder caused by either experiencing or witnessing traumatic incident such as a natural disaster, serious accident, sexual violence, a terrorist act. People of all the ages can get PTSD. Some people develop it after experiencing a shocking, scary, or dangerous event. It is natural to feel afraid during and after a traumatic situation. Fear causes many split-second changes in the body to defend against danger. This โfight-or-flightโ response is a common reaction designed to keep a person safe. Everyone experiences a range of reactions after trauma, but the majority of the recover from initial symptoms naturally. Those who continue to experience problems may be diagnosed with PTSD. People who have PTSD may feel stressed or frightened, even when they are not in danger.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
- Allergan PLC
- AstraZeneca
- Eli Lilly and Company
- GlaxoSmithKline PLC
- Sun Pharmaceuticals Pvt Ltd
- Bristol-Myers Squibb
- Johnson and Johnson
- Pfizer Inc.
- Aurobindo Inc.
- Teva Pharmaceuticals Industries Ltd.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/12965
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- This study presents the analytical depiction of the post-traumatic stress disorder market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the post-traumatic stress disorder market share.
- The current market is quantitatively analyzed from 2020 to 2030 to highlight the growth scenario of the post-traumatic stress disorder market..
- Porterโs five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and the competition that will take shape in the upcoming years.
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
COVID-19 is an infectious disease that first emerged in late December in the Hubei province of the Wuhan city in China. The virus that causes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly infectious and is transmitted person to person , The disease has spread to almost 213 countries across the globe ever since its outbreak in December 2019, compelling the World Health Organization to declare it a pandemic on March 11, 2020.
Coronavirus disease 2019 (COVID-19) has caused an economic crisis along with the healthcare crisis. The COVID-19 pandemic has stretched the global healthcare system; and developed countries are anticipated to experience an economic recession. The pandemic has had an adverse impact on the healthcare system, with revenue dropping by a 50% to 70% since March. Several small hospitals, clinics, and nursing homes, have been forced to shut their operations. Furthermore, social distancing and localized curfews have resulted in delayed elective surgical procedures. Moreover, visa cancellations have disrupted medical tourism which can negatively impact the growth of the healthcare services market.
COVID-19 infection and post-traumatic stress disorder do not have a direct connection but, the norms to stop the spread of the virus from person to person could be a potential trigger for post-trauma stress disorder. According to an article published by Psychiatric Times, there is a 16.8% of Chinese nurses suffer from PTSD symptoms.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/12965
Only two drugs (Sertraline and Paroxetine) have been approved by the USFDA for the treatment of post-traumatic stress disorder, however, both show adverse side effects., The regulatory bodies do not approve the medications without proper clinical trials considering their adverse effects.. These adverse effects are expected to hamper the growth of the PTSD treatment market., The primary side effects of sertraline include syncope, lightheadedness, diarrhea, nausea, sweating, dizziness, xerostomia, confusion, hallucinations, tremor, somnolence, impotency, fatigue, rhinitis, and female sexual disorder. Sertraline also, increases the risk of bleeding, as it may inhibit platelet aggregation.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com